DEFB131A
gene geneOn this page
Also known as DEFB-31
Summary
DEFB131A (defensin beta 131A, HGNC:18108) is a protein-coding gene on chromosome 4p16.1, encoding Beta-defensin 131A (P59861). Has antibacterial activity.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 4p16.
Source: NCBI Gene 644414 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 24 total
- MANE Select transcript:
NM_001040448
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18108 |
| Approved symbol | DEFB131A |
| Name | defensin beta 131A |
| Location | 4p16.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-31 |
| Ensembl gene | ENSG00000186146 |
| Ensembl biotype | protein_coding |
| Entrez | 644414 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334879
RefSeq mRNA: 1 — MANE Select: NM_001040448
NM_001040448
CCDS: CCDS43213
Canonical transcript exons
ENST00000334879 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001339101 | 9444414 | 9444591 |
| ENSE00001800099 | 9450360 | 9450666 |
Expression profiles
Bgee: expression breadth broad, 76 present calls, max score 84.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0800 / max 47.3043, expressed in 6 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 46904 | 0.0436 | 5 |
| 46905 | 0.0364 | 6 |
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| duodenum | UBERON:0002114 | 84.18 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.38 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 61.48 | gold quality |
| thyroid gland | UBERON:0002046 | 61.35 | gold quality |
| small intestine | UBERON:0002108 | 56.11 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 55.05 | gold quality |
| ventricular zone | UBERON:0003053 | 43.18 | gold quality |
| primary visual cortex | UBERON:0002436 | 39.02 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| intestine | UBERON:0000160 | 33.84 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| lymph node | UBERON:0000029 | 29.66 | gold quality |
| liver | UBERON:0002107 | 29.57 | gold quality |
| rectum | UBERON:0001052 | 27.83 | gold quality |
| blood | UBERON:0000178 | 27.17 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| muscle of leg | UBERON:0001383 | 26.94 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| leukocyte | CL:0000738 | 26.21 | gold quality |
| monocyte | CL:0000576 | 26.07 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.50 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MAPK14, RELA, TLR2
Literature-anchored findings (GeneRIF, showing 2)
- The protein encoded by this gene is thought to display antimicrobial activity. (PMID:16033865)
- DEFB131 induces cytokine and chemokine upregulation through the TLR2/NF-kappaB signaling pathway in RWPE-1 cells during bacterial infection and promotes an innate immune response (PMID:26649771)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb43 | ENSMUSG00000075572 |
| rattus_norvegicus | Defb43 | ENSRNOG00000038759 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 131A — P59861 (reviewed: P59861)
Alternative names: Beta-defensin 31, Defensin, beta 131
All UniProt accessions (1): P59861
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity. Upon stimulation with lipoteichoic acid, promotes cytokines and chemokines production and secretion.
Subcellular location. Secreted.
Tissue specificity. Highly expressed in testis. Is moderately expressed in the prostate and small intestine.
Induction. Up-regulated upon stimulation with lipoteichoic acid.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001035538* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
Pfam: PF13841
UniProt features (6 total): disulfide bond 3, signal peptide 1, peptide 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59861-F1 | 69.89 | 0.00 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 29–56, 36–50, 40–57
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 58 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE, GOBP_MYELOID_LEUKOCYTE_MIGRATION, GOBP_CELL_CHEMOTAXIS, GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS, GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE, GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND, GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION, GOBP_LEUKOCYTE_CHEMOTAXIS, GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION, GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS, GOBP_TAXIS, GOBP_LEUKOCYTE_MIGRATION, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM
GO Biological Process (3): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response (GO:0006952)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): obsolete extracellular space (GO:0005615), extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| response to stress | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
148 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB131A | DEFB127 | Q9H1M4 | 590 |
| DEFB131A | DEFB118 | Q96PH6 | 576 |
| DEFB131A | DEFB134 | Q4QY38 | 543 |
| DEFB131A | DEFB121 | Q5J5C9 | 530 |
| DEFB131A | CST5 | P28325 | 520 |
| DEFB131A | DEFB128 | Q7Z7B8 | 507 |
| DEFB131A | DEFB126 | Q9BYW3 | 480 |
| DEFB131A | DEFB129 | Q9H1M3 | 478 |
| DEFB131A | WFDC8 | Q8IUA0 | 478 |
| DEFB131A | DEFB110 | Q30KQ9 | 471 |
| DEFB131A | DEFB130A | P0DP74 | 461 |
| DEFB131A | DEFB132 | Q7Z7B7 | 436 |
| DEFB131A | DEFB123 | Q8N688 | 433 |
| DEFB131A | BPIFA3 | Q9BQP9 | 419 |
| DEFB131A | WFDC12 | Q8WWY7 | 417 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SGTA | DEFB131A | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB131A | AHNAK2 | psi-mi:“MI:0914”(association) | 0.350 |
| DEFB131A | SGTA | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (4): DEFB131 (Two-hybrid), AHNAK2 (Affinity Capture-MS), LRRC8A (Affinity Capture-MS), RBM12 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LNP1, A4H206, A4H207, A4H208, A4H209, A4H212, A4H213, P0C8A5, P0C8B0, P0DP73, P0DP74, P59861, P82020, P82172, Q30KJ3, Q30KJ5, Q30KJ6, Q30KJ8, Q30KJ9, Q30KK8, Q30KL4, Q30KL6, Q30KM9, Q30KP5, Q30KP6, Q30KP8, Q30KQ1, Q30KQ6, Q30KQ7, Q30KQ9, Q32ZF3, Q32ZF7, Q32ZG3, Q32ZH4, Q32ZH5, Q32ZH6, Q32ZI1, Q32ZI2, Q4QY38, Q6QLQ7
Diamond homologs: A0A096LNP1, P59861, Q30KJ8, Q30KM9, Q32ZF3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
155 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:9444589:CAGGT:C | donor_loss | 0.9900 |
| 4:9444593:T:A | donor_loss | 0.9800 |
| 4:9450356:A:AG | acceptor_gain | 0.9800 |
| 4:9447094:T:G | donor_gain | 0.9700 |
| 4:9450357:A:G | acceptor_gain | 0.9600 |
| 4:9444592:G:GG | donor_gain | 0.9500 |
| 4:9450358:A:AG | acceptor_gain | 0.9500 |
| 4:9450359:G:GG | acceptor_gain | 0.9500 |
| 4:9450359:GCCA:G | acceptor_gain | 0.9200 |
| 4:9447087:A:G | donor_gain | 0.8500 |
| 4:9450356:AAAGC:A | acceptor_gain | 0.8500 |
| 4:9450392:TCAGA:T | acceptor_gain | 0.8500 |
| 4:9450393:CAGAA:C | acceptor_gain | 0.8500 |
| 4:9450391:TTCAG:T | acceptor_gain | 0.8400 |
| 4:9450394:AGAA:A | acceptor_gain | 0.8400 |
| 4:9450355:TAAAG:T | acceptor_gain | 0.8300 |
| 4:9447073:G:GT | donor_gain | 0.8100 |
| 4:9450356:AAAG:A | acceptor_loss | 0.8100 |
| 4:9450358:AGCCA:A | acceptor_loss | 0.8100 |
| 4:9450390:CTTCA:C | acceptor_gain | 0.8100 |
| 4:9450395:G:T | acceptor_gain | 0.8000 |
| 4:9450357:AAGC:A | acceptor_gain | 0.7800 |
| 4:9450394:AGA:A | acceptor_loss | 0.7800 |
| 4:9450358:AGC:A | acceptor_gain | 0.7600 |
| 4:9444590:AG:A | donor_gain | 0.7500 |
| 4:9444591:GG:G | donor_gain | 0.7500 |
| 4:9450338:AATTT:A | acceptor_loss | 0.7200 |
| 4:9444587:TCCAG:T | donor_gain | 0.7100 |
| 4:9444588:CCAG:C | donor_gain | 0.7000 |
| 4:9450390:C:CT | acceptor_gain | 0.7000 |
AlphaMissense
467 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:9450419:T:A | C40S | 0.980 |
| 4:9450420:G:C | C40S | 0.980 |
| 4:9450470:T:A | C57S | 0.975 |
| 4:9450471:G:C | C57S | 0.975 |
| 4:9450471:G:A | C57Y | 0.973 |
| 4:9450419:T:C | C40R | 0.970 |
| 4:9450467:T:A | C56S | 0.966 |
| 4:9450468:G:C | C56S | 0.966 |
| 4:9450450:G:A | C50Y | 0.964 |
| 4:9450472:C:G | C57W | 0.964 |
| 4:9450467:T:C | C56R | 0.963 |
| 4:9450451:T:G | C50W | 0.962 |
| 4:9450449:T:A | C50S | 0.959 |
| 4:9450450:G:C | C50S | 0.959 |
| 4:9450469:C:G | C56W | 0.959 |
| 4:9450468:G:A | C56Y | 0.956 |
| 4:9450470:T:C | C57R | 0.956 |
| 4:9450407:T:A | C36S | 0.955 |
| 4:9450408:G:C | C36S | 0.955 |
| 4:9450409:C:G | C36W | 0.951 |
| 4:9450420:G:A | C40Y | 0.951 |
| 4:9450421:C:G | C40W | 0.950 |
| 4:9450471:G:T | C57F | 0.950 |
| 4:9450420:G:T | C40F | 0.948 |
| 4:9450449:T:C | C50R | 0.948 |
| 4:9450408:G:A | C36Y | 0.937 |
| 4:9450432:A:T | E44V | 0.933 |
| 4:9450407:T:C | C36R | 0.931 |
| 4:9450450:G:T | C50F | 0.922 |
| 4:9450433:A:C | E44D | 0.920 |
dbSNP variants (sampled 300 via entrez): RS1000559631 (4:9444826 A>T), RS1000736453 (4:9448920 A>G), RS1000785214 (4:9449196 C>T), RS10015493 (4:9443505 G>A), RS1001593422 (4:9449493 T>A,C), RS1001853493 (4:9445374 G>A), RS1002519068 (4:9447559 G>A,C), RS1002541331 (4:9445211 G>A,T), RS1002566188 (4:9443036 G>A,C), RS1002650340 (4:9451125 A>G), RS10027113 (4:9444147 C>A,G,T), RS10030667 (4:9447978 G>A,T), RS10031337 (4:9444066 A>G,T), RS10031636 (4:9444339 A>G), RS1003210254 (4:9447396 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007628_1 | Impulsivity (motor) | 3.000000e-07 |
| GCST008972_146 | Urate levels | 5.000000e-21 |
| GCST008972_48 | Urate levels | 2.000000e-35 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006946 | behavioural disinhibition measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| butyraldehyde | increases expression | 1 |
| pentanal | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.